HighMark Wealth Management »

Sutro Biopharma shares owned by HighMark Wealth Management

Quarter-by-quarter ownership of Sutro Biopharma (STRO) shares owned by HighMark Wealth Management from 13F filings

Historical chart of HighMark Wealth Management investment in Sutro Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Sutro Biopharma held by HighMark Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sutro Biopharma by HighMark Wealth Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $265 23 11.57

More positions owned by HighMark Wealth Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Russell 2000 Etf (IWM)
Axogen (AXGN)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p Us Vlu (IUSV)
Neogenomics Com New (NEO)
Wells Fargo & Company (WFC)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Anaptysbio Inc Common (ANAB)
Invesco Exch Traded Fd Tr Ii Dorsey Wrgt Smlc (DWAS)
Ishares Tr Core S&p Mcp Etf (IJH)
AtriCure (ATRC)
Si-bone (SIBN)

View all positions for HighMark Wealth Management

Top funds holding Sutro Biopharma

Affinity Asset Advisors
Kynam Capital Management
Vanguard Group
Acadian Asset Management
Velan Capital Investment Management
Vestal Point Capital
Samsara BioCapital
Eversept Partners
Opaleye Management
Point72 Asset Management
Tang Capital Management
Renaissance Technologies
BlackRock
GSA Capital Partners
Marshall Wace

View all funds holding Sutro Biopharma